Literature DB >> 16573781

Endoscopic sedation in the United States: results from a nationwide survey.

Lawrence B Cohen1, Julie S Wecsler, John N Gaetano, Ariel A Benson, Kenneth M Miller, Valerie Durkalski, James Aisenberg.   

Abstract

OBJECTIVES: The introduction of new sedative agents as well as a desire for improved patient satisfaction and greater efficiency has changed the practice of endoscopic sedation. This survey was designed to provide national and regional data on endoscopic sedation and monitoring practices within the United States.
METHODS: A 22-item survey regarding current practices of endoscopy and sedation was mailed to 5,000 American College of Gastroenterology physician members nationwide.
RESULTS: A total of 1,353 questionnaires (27.1%) were returned. Respondents performed an average of 12.3 esophagogastroduodenoscopies (EGDs) and 22.3 colonoscopies per wk. Endoscopic procedures were performed within a hospital setting (55.2) more often than at an ambulatory center (35.8%) or private office (8.8%). The vast majority of EGDs and colonoscopies (>98%) were performed with endoscopic sedation. Almost three quarters (74.3%) of the respondents used a narcotic and benzodiazepine for sedation, while propofol was preferred by 25.7%. Sedation practices varied considerably within different geographic regions of the United States. Respondents routinely monitored vital signs and pulse oximetry (99.2% and 98.6%, respectively), and supplemental oxygen was administered to all patients during EGD by 72.7% of endoscopists. Endoscopist satisfaction with sedation was greater among those using propofol than conventional sedation (10 vs 8, p < 0.0001).
CONCLUSIONS: During the past 15 yr, the volume of procedures performed by endoscopists in the United States has increased two- to fourfold. Propofol is currently being used for sedation in approximately one quarter of all endoscopies in the United States. The findings from this survey may help in the formulation of updated policies and practice guidelines pertaining to endoscopic sedation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16573781     DOI: 10.1111/j.1572-0241.2006.00500.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  143 in total

1.  Incidence of propofol injection pain and effect of lidocaine pretreatment during upper gastrointestinal endoscopy.

Authors:  Ji Suk Kwon; Eun Soo Kim; Kwang Bum Cho; Kyung Sik Park; Woo Young Park; Jeong Eun Lee; Tae Yol Kim; Byoung Kuk Jang; Woo Jin Chung; Jae Seok Hwang
Journal:  Dig Dis Sci       Date:  2011-12-13       Impact factor: 3.199

2.  Does anesthesiologist-directed sedation for ERCP improve deep cannulation and complication rates?

Authors:  Paresh P Mehta; John J Vargo; John A Dumot; Mansour A Parsi; Rocio Lopez; Gregory Zuccaro
Journal:  Dig Dis Sci       Date:  2011-01-28       Impact factor: 3.199

3.  Endoscopic sedation in developing and developed countries.

Authors:  Ariel A Benson; Lawrence B Cohen; Jerome D Waye; Alaleh Akhavan; James Aisenberg
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

4.  Anti-hypertensive therapy and risk factors associated with hypotension during colonoscopy under conscious sedation.

Authors:  Derek M Tang; Kellie Simmons; Frank K Friedenberg
Journal:  J Gastrointestin Liver Dis       Date:  2012-06       Impact factor: 2.008

5.  Review on sedation for gastrointestinal tract endoscopy in children by non-anesthesiologists.

Authors:  Rok Orel; Jernej Brecelj; Jorge Amil Dias; Claudio Romano; Fernanda Barros; Mike Thomson; Yvan Vandenplas
Journal:  World J Gastrointest Endosc       Date:  2015-07-25

Review 6.  Sedation in gastrointestinal endoscopy: current issues.

Authors:  John K Triantafillidis; Emmanuel Merikas; Dimitrios Nikolakis; Apostolos E Papalois
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Analysis of cardiopulmonary stress during endoscopy: is unsedated transnasal esophagogastroduodenoscopy appropriate for elderly patients?

Authors:  Kazuhiko Uchiyama; Takeshi Ishikawa; Naoyuki Sakamoto; Hirokazu Kajikawa; Tomohisa Takagi; Osamu Handa; Yoshihide Tatsumi; Nobuaki Yagi; Yuji Naito; Yoshito Itoh; Shuhei Takemura
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-28

8.  Sedation methods can determine performance of endoscopic submucosal dissection in patients with gastric neoplasia.

Authors:  Chan Hyuk Park; Jae Hoon Min; Young-Chul Yoo; Hyunzu Kim; Dong Hoo Joh; Jung Hyun Jo; Suji Shin; Hyuk Lee; Jun Chul Park; Sung Kwan Shin; Yong Chan Lee; Sang Kil Lee
Journal:  Surg Endosc       Date:  2013-02-07       Impact factor: 4.584

9.  Split dose and MiraLAX-based purgatives to enhance bowel preparation quality becoming common recommendations in the US.

Authors:  Grace Clarke Hillyer; Benjamin Lebwohl; Corey H Basch; Charles E Basch; Fay Kastrinos; Beverly J Insel; Alfred I Neugut
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

10.  Remifentanil compared with midazolam and pethidine sedation during colonoscopy: a prospective, randomized study.

Authors:  Maria M Manolaraki; Angeliki Theodoropoulou; Charalampos Stroumpos; Emmanouil Vardas; Pantelis Oustamanolakis; Aliki Gritzali; Gregorios Chlouverakis; Gregorios A Paspatis
Journal:  Dig Dis Sci       Date:  2007-05-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.